openPR Logo
Press release

CAR T Cell Therapy Market to 2027, Future Outlook, COVID-19 Impact Analysis, Forecast 2021-2027

12-22-2021 07:46 AM CET | Health & Medicine

Press release from: Orion Market Research

The global CAR T cell therapy market is estimated to witness potential growth during the forecast period. Research institutes and biopharmaceutical companies are focusing on the development and commercialization of CAR T cell therapy coupled with the increasing FDA approvals for cell-based therapies owing to its demonstrated safety and efficacy in initial trials. This therapy may create hope for cancer patients to achieve complete remission of their condition. Partnerships for CAR T cell therapy has been witnessed to develop and commercialize therapies, which in turn, is expected to support the companies to increase their market share in the CAR T cell therapies.

A full report of CAR T Cell Therapy Market is available at: https://www.omrglobal.com/industry-reports/car-t-cell-therapy-market

Partnerships focused on development and commercialization of CAR T cell therapy
In May 2019, Kite, a Gilead Co. and Humanigen, Inc. declared partnership for conducting Phase 1/2 clinical study to assess the combination of lenzilumab, an investigational anti-GM-CSF monoclonal antibody and Yescarta, the CAR T therapy for treatment of patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). This study aims to define the effect of lenzilumab on Yescarta safety. Kite will be responsible to conduct this study and act as a sponsor for the study.

In November 2019, Takeda Pharmaceutical Co. Ltd. and the University of Texas MD Anderson Cancer Center declared research and license agreement for the development of blood-derived CAR-directed natural killer (CAR NK)-cell therapies, ‘armored’ with IL-15. This therapy is intended for the treatment of B-cell malignancies and other cancers. Under the agreement, Takeda Pharmaceutical will get the rights to develop and commercialize up to four programs, such as a B-cell maturation antigen (BCMA)-targeted CAR NK-cell therapy and CD19-targeted CAR NK-cell therapy. In addition, it will obtain access toMD Anderson CAR NK platform.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/car-t-cell-therapy-market

In June 2019, Servier, aglobal pharmaceutical company, and Yposkesi, a leading contract development and manufacturing organization(CDMO)to producegene therapy viral vector, declared that they have signed a manufacturing service agreement.For the development and GMP production of lentiviral vectors, Servier selected Yposkesi which willcontribute to the development of allogenic CAR-T cell technology.

In April 2018, Pfizer Inc. and Allogene Therapeutics, Inc. entered into an asset contribution agreement which aims for the portfolio of Pfizer assets associated with allogeneic CAR T therapy, an investigational immune cell therapy approach for cancer treatment. With this agreement, Pfizer is looking for an opportunity to continuously support the development of allogeneic CAR T therapy. Pfizer will continuously be engaged financially to develop the CAR T portfolio with a 25% ownership stake in Allogene. Additionally, Pfizer has an 8% ownership stake in Cellectis with an equity agreement entered in 2014.
This increasing focus on clinical trials for CAR T cell therapy is providing enormous opportunity for the global CAR T cell therapy market. Moreover, Allogeneic CAR T cell therapies have an opportunity to become the next innovation among highly potential anti-cancer agents and eliminate the requirement for the development of personalized therapy from own cells of the patient. Such therapies are developed from healthy donors’ cells and stored for use “off-the-shelf” among patients that can facilitate the production process and minimizing waiting time for patients.

CAR T cell Therapy Market Segmentation

By Application

• Non-Hodgkin Lymphoma
• Acute Lymphocytic Leukemia
• Others (Multiple Myeloma, Hodgkin Lymphoma, and Breast Cancer)

By Target Antigen

• CD19
• CD22
• Others (CD123, CD33, and BCMA)

CAR T Cell Therapy Market– Segment by Region

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• Amgen Inc.
• Autolus Therapeutics plc
• bluebird bio, Inc.
• Bristol-Myers Squibb Co.
• CARsgen Therapeutics Co., Ltd.
• Cellectis SA
• Celyad SA
• Gilead Sciences, Inc.
• Intellia Therapeutics, Inc.
• Janssen Global Services, LLC (a Subsidiary of Johnson & Johnson)
• LesLaboratoiresServier, SAS
• Mustang Bio
• Nanjing Legend Biotechnology Co., Ltd.
• Noile-Immune Biotech Inc.

Reasons to Buying From us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release CAR T Cell Therapy Market to 2027, Future Outlook, COVID-19 Impact Analysis, Forecast 2021-2027 here

News-ID: 2507444 • Views:

More Releases from Orion Market Research

AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2033
AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033. AI-Enabled Imaging Modalities Market Overview The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry Growths to 2033
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034. SNP genotyping Market Overview The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This

All 5 Releases


More Releases for CAR

Car Washing Services Market Is Booming So Rapidly with Mister Car Wash, Zips Car …
The Car Washing Services Market has been fragmented based on the productivity of several companies; therefore, each segment and its sub-segments are analyzed in the research report. Furthermore, the report offers 360 views on historical and upcoming growth based on volume, value, production, and consumption. Moreover, it classifies depend on sub-segments, key segments as per the significant regions and offers an in-depth analysis on the competitive edge of the market.
Car Wash Service Market Boosting the Growth Worldwide: Auto Bell Car Wash, Miste …
The latest study released on the Global Car Wash Service Market by AMA Research evaluates market size, trend, and forecast to 2027. The Car Wash Service market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors. Key
Car Rental Services Market Forecast to 2028 Covid-19 Impact and Global Analysis …
Car rental services are a process of hiring/renting a car for a limited period from a rental company. Various companies like Uber Technologies, Europcar rent the vehicles for a short period ranging from few hours to weeks. The different types of cars rented by the company include Luxury Car, executive car, and economical car among others. Additionally, vehicle renting agencies also offer other products such as insurance, entertainment systems, and
Car Rentals Market Growth Strategies and Innovative Technology Transformation by …
Worldwide Market Reports has announced the addition of the "Car Rentals Market Report 2020-2027 Production, Sales And Consumption Status And Prospects Professional Research", The report classifies the global Car Rentals Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. The emergence of own-brand digital ordering platform has been trending in the global Car Rentals market. Car Rentals such as
Luxury Car Leasing Market Competitors Analysis By German Rent A Car, ANI Technol …
'Global Luxury Car Leasing Market Research Report' the report is complete with an elaborate research undertaken by prominent analysts and a detailed analysis of the global industry place. The Luxury Car Leasing report is fragmented in several features which include manufacturers, region, type, application, market status, market share, growth rate, future trends, market drivers, opportunities, challenges, emerging trends, risks, entry barriers, sales channels, and distributors which are again elaborated in
Car Wash Market is Thriving Worldwide 2026 | Super Star Car Wash, Autobell Car W …
This Car Wash Market research report offers you an array of insights about Automotive industry and business solutions that will support to stay ahead of the competition. Systematic investment analysis is also underlined in this Car Wash Market report which forecasts impending opportunities for the market players.This market report is the outcome of persistent efforts lead by knowledgeable forecasters, innovative analysts and brilliant researchers who carries out detailed and diligent